GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...
In particular, it shows that a subset of people with highly inflammatory arthralgia might benefit from methotrexate, allowing inhibition of the onset of arthritis. Furthermore, molecular analyses in ...
The (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines ...
City of Hope and Biopharmaceutical Research Company announce first patient has received BRC-001, an experimental supportive care therapy for breast cancer patients. City of Hope researchers and a ...